SeaStar Medical (NASDAQ:ICU) Announces Earnings Results

SeaStar Medical (NASDAQ:ICU) announced its quarterly earnings data on Thursday. The company reported ($0.90) earnings per share for the quarter, Zacks reports.

SeaStar Medical Price Performance

Shares of ICU stock traded down $0.23 on Thursday, hitting $2.20. 346,809 shares of the stock traded hands, compared to its average volume of 250,448. The company’s fifty day moving average is $1.86 and its 200 day moving average is $2.65. SeaStar Medical has a 1-year low of $1.50 and a 1-year high of $20.70. The company has a market capitalization of $14.24 million, a PE ratio of -0.19 and a beta of -0.97.

About SeaStar Medical

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome.